Navigation Links
Adamas Pharmaceuticals Presents Positive Clinical Data For ADS-5102, A Treatment For Levodopa-Induced Dyskinesia, At The World Parkinson's Congress
Date:10/2/2013

160; Adamas is investigating whether the novel pharmacokinetic profile and low overnight amantadine plasma concentration may reduce the insomnia, sleep disturbances, and vivid dreams occasionally associated with amantadine.  ADS-5102 is being investigated in clinical studies at once-nightly dose strengths 1.3 to 2.1 fold greater than the 100 mg twice-daily dose typically used with immediate-release amantadine.

About Levodopa-Induced Dyskinesia
Levodopa (also known as L-dopa) remains the gold standard for the treatment of the debilitating motor symptoms of Parkinson's disease.  An unfortunate side effect of prolonged treatment with levodopa is the occurrence of levodopa-induced dyskinesia (LID).  LID is characterized by involuntary non-purposeful movements of the head and neck, arms, legs or trunk.  With continued levodopa treatment, and as PD progresses, LID can become severely disabling and has been associated with a decrease in the quality of life for Parkinson's patients.1  LID affects approximately 30 percent of patients taking levodopa2, and is particularly problematic among young-onset Parkinson's disease patients.  There are currently no medications approved for the treatment of LID.  Reducing LID and improving ON time without troublesome dyskinesia are among the greatest patient unmet medical needs in the treatment of advanced Parkinson's disease.3

About Adamas Pharmaceuticals, Inc.
Adamas Pharmaceuticals is dedicated to improving the lives of those affected by central nervous system (CNS) disorders by optimizing the pharmacokinetic profiles of approved drugs to create novel treatments for use alone and as components of fixed-dose combination products.  The Company is currently advancing a pipeline of aminoadamantane-based drug candidates for the treatment of Parkinson's disease, Alzheimer's disease, and other CNS disorders.  The Phase 2/3 EASED study invest
'/>"/>

SOURCE Adamas Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
2. Adamas Pharmaceuticals To Report Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia In Parkinsons Disease
3. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
4. Adamas Pharmaceuticals presenta datos clínicos positivos para ADS-5102, un tratamiento para la disquinesia inducida por levodopa, en el Congreso Mundial del Parkinson
5. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
6. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
7. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
8. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
9. Icahn Issues Statement Regarding Amylin Pharmaceuticals
10. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
11. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , Aug. 3, 2015  Sage Analytics ( www.sageanalytics.com ... laboratory-quality cannabis potency measurement systems, announced its sponsorship of ... Cruise Fundraiser. A limited number of tickets are available ... help a great cause while enjoying an open bar, ... around the San Francisco Bay at sunset. ...
(Date:8/3/2015)... August 3, 2015 Global ... to reach USD 24.7 billion by 2022, according ... Inc. Growing prevalence of neurological and musculoskeletal disorders ... over the forecast period. The presence of efficient ... advancement in the technologies coupled with implementation of ...
(Date:8/3/2015)... SINGAPORE , Aug. 3, 2015 ... Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a ... today announced financial results for its first fiscal ... Quarter Highlights and Recent Developments: ... progress in improving its cost structure, driven by ...
Breaking Medicine Technology:Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 3Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 4Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6
(Date:8/3/2015)... ... August 03, 2015 , ... sweetFrog Enterprises, LLC. is pleased ... the 20th sweetFrog store operating in the Lone Star State. The premium frozen yogurt ... in 2014. , The store, located at 2916 US-75, Sherman, TX 38652, will have ...
(Date:8/3/2015)... ... 03, 2015 , ... As reported in a July ... “Atlanta Plastic” is getting attention for moving outside traditional ethnic stereotypes when it ... cast of doctors and patients. Beverly Hills based plastic surgeon Payam Jarrah-Nejad, M.D., ...
(Date:8/3/2015)... NJ (PRWEB) , ... August 03, 2015 , ... ... a finalist in 2015 MarketingProfs Bright Bulb B2B Awards. , The MarketingProfs Bright ... and for B2B brands. BESLER Consulting's campaign for the launch of their Readmissions ...
(Date:8/3/2015)... Somerset, N.J. (PRWEB) , ... August 03, 2015 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... Administration has accepted for review OPKO’s New Drug Application for a new treatment ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... The art ... experience. Learning from her grandmother’s side at a young age, Nasreen Zereshki was extremely ... has decided to share her cookbook Recipes from My Persian Kitchen with the world. ...
Breaking Medicine News(10 mins):Health News:sweetFrog Reopens Texas Store Today 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 3Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2
... to extend their reach beyond the youth segments as far as ... For the aging population in Japan has taken to "Brain Train" ... Nintendo has sold 3.3 million of its "Brain Training for Adults" ... out to those who were not interested in video games ... ...
... People plan various phases of their life like education, marriage, ... do not plan for the most important thing - death. ... University of New Mexico's Health Sciences Center wants people to ... ,"We're all going to die. But we do not address ...
... (KSHV) and certain forms of lymphoma has been ... ,Researchers at the National Institute of Allergy ... human cell surface molecule involved in infection by ... Kaposi's sarcoma and certain forms of lymphoma. Kaposi's ...
... sporting sunglasses, don’t be surprised. They don't mean to be ... their looks! //Sunglasses have always afforded creative utility benefits and ... use. There is one more out of the hat use ... who have revealed that sunglasses can help reduce jet lag. ...
... culprit behind childhood obesity is that the amount of junk ... of hours they spend// watching television. Researchers analyzed the dietary ... countries. , It was found that consumption of ... in front of the idiot box. Researchers at the universities ...
... which is a male-dominated Muslim society, five women undergo sex ... are expected to fully cover themselves in public and ban ... relative. ,Hence five Saudi women took a sex ... developed a psychologic complex. ,Al Watan newspaper quoted ...
Cached Medicine News:Health News:Plan for Death, Health Center Advises People 2Health News:Virus Causing Kaposi's Sarcoma Discovered 2Health News:Virus Causing Kaposi's Sarcoma Discovered 3Health News:TV Viewing Increases Intake of Junk Food 2
Uvex Patriot Frame...
... are designed with the safety and comfort of ... RS-520 (also called SF-6) leaded glass, the industry ... standards, as set for optical clarity, visible light ... eyewear is protecting your eyes, it also helps ...
... Goggles fit over glasses ... by the whole department! ... 1.0 mm leaded glass ... scatter radiation protection. Clear ...
Qualcraft™ Radiation Protection Eyewear, Metal, Bifocal. Provides maximum comfort and eye protection! Plano (nonprescription). Black with bronze temple bar....
Medicine Products: